Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA's Allergy Drug Safe For Non-Prescription Use-FDA Reviewers-Reuters


Monday, 29 Jul 2013 09:58am EDT 

Reuters reported that Sanofi SA's allergy drug Nasacort AQ is safe enough to be used without a prescription, according to reviewers for the U.S. Food and Drug Administration. The reviewers, whose opinions were posted on the FDA's website on July 29, 2013, said the nasal spray, which currently requires a prescription, has a favorable risk-benefit profile for over-the-counter use. An advisory committee to the FDA is to decide on July 31, 2013 whether to recommend making Nasacort AQ an over-the-counter product. The drug is used to treat hay fever and other respiratory allergies. 

Company Quote

75.66
-0.75 -0.98%
11 Jul 2014